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the heart by infusing the cardioplegic solution under aortic
occlusion by means of the balloon throughout the procedure.
Even though the balloon catheter passes through the aortic
valve, significant aortic valve insufficiency is not likely to
occur because of the small caliber of the balloon catheter. We
believe that the clinical application of this double-lumen aor-
tic occlusion catheter will protect the myocardium in patients
with a thoracoabdominal aortic aneurysm or distal descend-
ing aortic aneurysm who undergo the operation through the
left thoracotomy with DHCA.
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MODIFIED HEMI-FONTAN PROCEDURE ON THE BEATING HEART
Franz-Xaver Schmid, MD, Friedrich Wippermann, MD, Christoph Kampmann, MD, Michael Hilker, MD, and 
Hellmut Oelert, MD, Mainz, Germany
Indication, timing, and type of surgical intervention in
patients with single ventricle physiologic condition are a con-
tinuing challenge. For patients who have significant risk fac-
tors for a poor Fontan outcome, the bidirectional cavopul-
monary anastomosis has been shown to be an effective
staging procedure by providing pulmonary blood flow with-
out volume loading of the single ventricle.1,2 It offers the ben-
efit of a relatively simple surgical approach and can be per-
formed as a closed procedure with the heart beating on partial
cardiopulmonary bypass. However, later completion of the
Fontan circulation can only be accomplished by extensive
dissection of the cardiac end of the superior vena cava and of
the right atrium. Additionally, there may be an increased risk
for arrhythmias and phrenic nerve palsy. Therefore the so-
called hemi-Fontan procedure, including an anastomosis
between both ends of the divided superior vena cava and the
pulmonary artery in conjunction with an intraatrial patch
occlusion of the cavoatrial junction, was introduced.3 This
procedure involves opening of the right atrium during a short
period of aortic crossclamping and cardioplegic arrest and
may increase the overall risk of the operation. We developed
an alternative technique for a hemi-Fontan procedure on car-
diopulmonary bypass without the requirement for aortic
crossclamping.
Technique. The operation is performed through a median
sternotomy incision. Cardiopulmonary bypass is established
by aortic perfusion and drainage via cannulation of the right
atrium and the innominate vein. Clamps are placed on the
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Fig 1. Schematic display of the operative procedure:
Proximally eversion is facilitated by dissection and mobiliza-
tion of the full length of the superior vena cava (SVC). RPA,
Right pulmonary artery; MPA, main pulmonary artery; RA,
right atrium.
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superior vena cava with some distance superior to the cavoa-
trial junction and just below the innominate vein orifice. The
superior vena cava is transected at the level of the superior
margin of the right pulmonary artery. The cut edges of the
cardiac end of the divided superior vena cava are everted with
gentle axial traction. The venous stump is kept everted until a
patch is sutured within the superior vena cava near its
entrance site to the right atrium (Fig 1). After complete inter-
nal occlusion, the eversion is reduced. The operation is com-
pleted with the creation of a total cavopulmonary connection
with anastomosis of the cranial and cardiac end of the divid-
ed superior vena cava into a longitudinal incision in the supe-
rior and inferior aspect of the right pulmonary artery. Thus a
hemi-Fontan circulation is established (Fig 2). Subsequent
completion of the Fontan procedure requires the excision of
the patch from within the right atrium and construction of the
lateral atrial tunnel.
Patients and results. From June 1, 1996, to April 30, 1998,
14 infants with hypoplastic left heart syndrome who survived
the Norwood procedure (including pulmonary artery to
ascending aorta anastomosis with homograft augmentation of
the aortic arch, atrial septectomy, and placement of a 3.5-mm
modified right Blalock-Taussig shunt) underwent a modified
hemi-Fontan operation as an intermediate stage for an even-
tual Fontan procedure at our institution. The hemi-Fontan
operation was performed at a mean age of 7.6 ± 5.4 months
(range, 3 to 14 months). Mean bypass time was 68.9 minutes
(range, 40 to 127 minutes). All surgical procedures were per-
formed while the heart was beating. Oxygen saturation after
discontinuation of cardiopulmonary bypass was 83.1% (75%
to 88%). There was no operative death. The early postopera-
tive course was smooth in all patients, with weaning from the
ventilator and discharge to the ward between 2 and 6 days
after the operation. The youngest patient in this series had
significant pleural effusions and required chest tube drainage
for 5 days. Chylothorax occurred in one patient.
Three weeks of a fat-free diet was required for cure. No
arrhythmias occurred, and no antiarrhythmic medication be-
came necessary.
After a period of 8, 12, and 13 months of follow-up in 3
patients, the hemi-Fontan circulation was converted to a com-
plete Fontan circulation by placement of an intra-atrial baffle.
During the short follow-up period, no complications
occurred. All patients are alive and well.
Comment. The hemi-Fontan operation (functional bidirec-
tional cavopulmonary anastomosis) has proved to be a safe
and effective preparatory stage for a Fontan procedure, espe-
cially in young and high-risk candidates.4 The technical mod-
ification that is reported here offers several potential advan-
tages. The total cavopulmonary anastomosis can be performed
on normothermic cardiopulmonary bypass with the heart beat-
ing. Avoiding myocardial ischemia may be of substantial
importance in patients with increased surgical risk, as are
patients experiencing second-stage palliation of hypoplastic
left heart syndrome.5 The absence of intra-atrial suture lines
by performing an extracardiac occlusion of the superior vena
cava at its right atrial junction and the avoidance of extensive
dissection at the time of the Fontan completion may contribute
to decrease the incidence of atrial arrhythmias. Moreover, cre-
ation of the inferior cavopulmonary anastomosis is facilitated
because it can be performed when the clamp at the cardiac end
is already released.
An adequate length of the cardiac end of the superior vena
cava is critical for its eversion. Ligation and division of small
venous branches draining to the superior vena cava and of the
azygos vein allow extensive mobilization of the superior vena
cava. Azygos continuation of the inferior vena cava may sig-
nificantly reduce the length of the vein available for the anas-
tomosis. Thus the vascular clamp has to be placed near the
cavoatrial junction, with the sinus node at risk for damage. In
this situation we do not recommend our modified surgical
procedure.
In patients with an additional left superior vena cava, this
also is anastomosed to the pulmonary artery in an end-to-side
fashion but is oversewn at its cardiac end. Moreover, ensuing
completion of the Fontan circulation after the aforementioned
hemi-Fontan modification can also be performed easily as a
total extracardiac cavopulmonary procedure.
In conclusion, the hemi-Fontan operation can be accom-
plished without cardiac arrest and low operative morbidity
and mortality in the setting of hypoplastic left heart syndrome
and in most patients with a functional single ventricle. Long-
term follow-up of this technique will provide further infor-
mation on its potential advantages.
Fig 2. Lateral angiogram reveals wide patency of the cavo-
pulmonary anastomoses and closure of the cavoatrial junc-
tion. The angiogram was performed during follow-up study
before Fontan completion. Bidirectional pulmonary blood
flow is noted.
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IN SITU IMPLANTATION OF A PROSTHETIC SYSTEMIC ATRIOVENTRICULAR VALVE IN CORRECTED
TRANSPOSITION
Amir Elami, MD, Arthur Pollak, MD, and Gideon Merin, MD, Jerusalem, Israel
Tricuspid valve abnormalities are common in patients with
corrected transposition of the great arteries (C-TGA).1-3
Anatomic abnormalities include Ebstein’s malformation,
straddling, dysplasia, or simply inferior displacement of the
coaptation point. As a consequence, systemic atrioventricular
valve insufficiency is common, occurring in up to 33% of
patients with C-TGA.3,4 This valvular dysfunction is signifi-
cant in that its presence or development negatively affects
survival, whether treated surgically or not.1,4,5 Systemic
(right) ventricular dysfunction often coexists in these
patients, making it difficult to define the relative contribution
of each abnormality to the progression of heart failure and
shortening of survival. In contrast to normally located regur-
gitant tricuspid valves, where even in the presence of
Ebstein’s anomaly over 50% can be repaired successfully,
left-sided tricuspid valves need to be replaced in most cases.
The conventional technique of valve replacement involves
excision, with loss of the continuity between the valve anu-
lus, valve tissue, chordae, and ventricular wall. Preservation
of the subvalvular apparatus has been shown to maintain left
ventricular performance after mitral valve replacement in
both animal models and clinical studies. We applied this con-
cept to 2 patients with C-TGA and tricuspid regurgitation
requiring tricuspid valve replacement (TVR).
Clinical summaries
PATIENT 1. This patient was born in June 1990. During the
first year of his life, he was hospitalized frequently because
of pulmonary infections as the result of congestive heart fail-
ure. Echocardiography identified C-TGA, a membranous
ventricular septal defect, a patent foramen ovale, mild pul-
monic stenosis, and significant tricuspid regurgitation caused
by Ebstein’s anomaly. Although dilated, right ventricular
(systemic) function was normal. At 3.5 years of age, he
underwent closure of the patent foramen ovale and ventricu-
lar septal defect, with implantation of a permanent atrioven-
tricular (DDD) pacemaker because of intermittent complete
atrioventricular block. Because he had normal right ventricu-
lar function at that time, it was decided to withhold surgical
intervention for the tricuspid valve. After this procedure he
remained asymptomatic for 12 months. He then started to
have shortness of breath, and cardiac enlargement was evi-
dent, despite full medical treatment of congestive heart fail-
ure. Echocardiography at 5 years of age revealed moderate
deterioration of systolic right ventricular function with frac-
tional shortening (FS) of 18%. Subsequently, he underwent
TVR. The septal leaflet of the valve was displaced down-
ward, and the anulus was dilated, thereby precluding leaflet
coaptation. A 27-mm St Jude Medical prosthesis (St Jude
Medical, Inc, St Paul, Minn) was implanted into the tricuspid
valve anulus. This was achieved by interrupted stitches that
ran from the atrial aspect through the anulus and around the
free edge of each leaflet and then into the prosthesis sewing
ring. The leaflets were therefore folded along the anulus.
When examined 1 month later, he denied any symptoms.
Echocardiography revealed improvement in right ventricular
function (FS, 23%) with a normally functioning prosthetic
valve. In addition, he regained sinus rhythm. During his last
follow-up visit, 29 months after TVR, echocardiography
demonstrated a normal size-for-age systemic ventricle with
mildly reduced systolic function (FS, 25%). 
PATIENT 2. This patient was initially diagnosed at the age of
6 months as having situs inversus and dextrocardia. A heart
murmur was also noted. In November 1992, when she was 53
years old, she started having shortness of breath on exertion.
Echocardiographic findings failed to diagnose C-TGA but
were instead read as severe “mitral regurgitation,” moderate
“tricuspid regurgitation,” and normal-size “left ventricle.”
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